指南与共识肺结节与肺癌呼吸道感染

COVID-19大流行期间肺结节管理与肺癌筛查:CHEST专家小组报告

Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report.
指南 / 共识 · Chest · 2020-04-23

由24名专家组成的CHEST专家小组针对COVID-19大流行期间肺癌筛查和肺结节评估的12个临床场景制定共识声明,采用70%同意阈值投票。共识认为可推迟筛查入组、暂缓结节监测影像并减少非紧急干预,但需结合局部和患者因素个体化应用。

要点

  • COVID-19期间可适当推迟肺癌筛查入组和肺结节监测影像。
  • 肺结节评估中应尽量减少非紧急干预以节省资源。
  • 共识需结合本地资源和患者因素个体化应用。

核心结论

  • 专家组共识认为COVID-19大流行期间可推迟肺癌筛查入组并调整肺结节评估。

研究设计与样本

  • 24名专家(呼吸科17名、胸部放射科5名、胸外科2名)组成小组,通过视频会议讨论并投票,以70%同意或强烈同意为共识阈值。

主要发现

  • 针对12个常见临床场景制定并修改了12条声明,全部达到共识阈值。
  • 声明涵盖基线与年度筛查(2条)、已检出结节监测(5条)、中高危结节评估(4条)及临床I期非小细胞肺癌管理(1条)。

关键数值与推荐

  • 共识阈值定义为70%的小组成员投票同意或强烈同意。

临床怎么用

  • 应用共识时应考虑局部、区域及患者相关因素以个体化决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The risks from potential exposure to coronavirus disease 2019 (COVID-19), and resource reallocation that has occurred to combat the pandemic, have altered the balance of benefits and harms that informed current (pre-COVID-19) guideline recommendations for lung cancer screening and lung nodule evaluation. Consensus statements were developed to guide clinicians managing lung cancer screening programs and patients with lung nodules during the COVID-19 pandemic. METHODS: An expert panel of 24 members, including pulmonologists (n = 17), thoracic radiologists (n = 5), and thoracic surgeons (n = 2), was formed. The panel was provided with an overview of current evidence, summarized by recent guidelines related to lung cancer screening and lung nodule evaluation. The panel was convened by video teleconference to discuss and then vote on statements related to 12 common clinical scenarios. A predefined threshold of 70% of panel members voting agree or strongly agree was used to determine if there was a consensus for each statement. Items that may influence decisions were listed as notes to be considered for each scenario. RESULTS: Twelve statements related to baseline and annual lung cancer screening (n = 2), surveillance of a previously detected lung nodule (n = 5), evaluation of intermediate and high-risk lung nodules (n = 4), and management of clinical stage I non-small cell lung cancer (n = 1) were developed and modified. All 12 statements were confirmed as consensus statements according to the voting results. The consensus statements provide guidance about situations in which it was believed to be appropriate to delay screening, defer surveillance imaging of lung nodules, and minimize nonurgent interventions during the evaluation of lung nodules and stage I non-small cell lung cancer. CONCLUSIONS: There was consensus that during the COVID-19 pandemic, it is appropriate to defer enrollment in lung cancer screening and modify the evaluation of lung nodules due to the added risks from potential exposure and the need for resource reallocation. There are multiple local, regional, and patient-related factors that should be considered when applying these statements to individual patient care.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Mazzone PJ, Gould MK, Arenberg DA, et al. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest. 2020. PMID: 32335067. doi:10.1016/j.chest.2020.04.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。